Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
91.53
+1.45 (1.61%)
At close: Jul 3, 2025, 1:00 PM
90.60
-0.93 (-1.02%)
After-hours: Jul 3, 2025, 4:58 PM EDT
Verona Pharma Employees
Verona Pharma had 209 employees as of December 31, 2024. The number of employees increased by 130 or 164.56% compared to the previous year.
Employees
209
Change (1Y)
130
Growth (1Y)
164.56%
Revenue / Employee
$567,153
Profits / Employee
-$784,416
Market Cap
8.34B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VRNA News
- 25 days ago - Verona Pharma: A Blockbuster Franchise In The Making - Seeking Alpha
- 6 weeks ago - Verona Pharma Announces June 2025 Investor Conference Participation - GlobeNewsWire
- 2 months ago - Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025 - GlobeNewsWire
- 2 months ago - Silencing The Doubters: Verona Pharma Could Be Sitting On A Blockbuster - Seeking Alpha
- 2 months ago - Verona Pharma plc (VRNA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Verona Pharma's Bull Case Holds, But Lifecycle Extension Is Critical - Seeking Alpha
- 3 months ago - Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS - GlobeNewsWire